Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples